NDC product
Terazosin hydrochloride
NDC 0093-4338 · Teva Pharmaceuticals USA Inc
Key facts
| Product NDC | 0093-4338 |
|---|---|
| Proprietary name | Terazosin hydrochloride |
| Labeler | Teva Pharmaceuticals USA Inc |
| Marketing category | ANDA |
| Application number | ANDA075614 |
| Marketing start | Sep 8, 2009 |
| Marketing end | Sep 30, 2014 |
| Listing certified through | Sep 30, 2014 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: